Nursing care in patients with osteogenesis imperfecta. A case study

被引:0
|
作者
Alonso Blanco, Cristina [1 ]
Checa Blanco, Maria J. [2 ]
机构
[1] Ctr Salud Navas Rey, Area Atenc Primaria 8, Madrid, Spain
[2] Fdn Hosp Alcorcon, Area 8, Madrid, Spain
来源
ENFERMERIA CLINICA | 2005年 / 15卷 / 05期
关键词
Osteogenesis imperfecta; Nursing care; Nursing care process; Therapeutic measures;
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Osteogenesis imperfecta (OI) constitutes, within the group of bone dysplasias, a set of congenital disorders of collagen type 1 fibers. These mutations generate a biochemical defect that translates into a complex clinical picture: low stature, bone deformities, osteopenia, respiratory and cardiovascular problems, and dentinogenesis imperfecta. The 3 main lines of treatment for OI within which nursing care is developed are: a) to prevent and control the clinical manifestations of the disease, so that normal development of the child is encouraged; b) to promote maximal physical, emotional and social independence of sufferers, preventing the development of complications such as fractures and deformities, and c) to provide health education to sufferers and those in their environment, especially their parents. The aim of the present article is to provide, through a case study, basic knowledge this disease, which is of great therapeutic importance because of its severe associated deformities and disabilities.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [21] Alendronate in the treatment of pediatric osteogenesis imperfecta.
    Glorieux, FH
    Rauch, F
    Ward, LM
    Smith, P
    Verbruggen, N
    Heyden, N
    Lombardi, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S12 - S12
  • [22] Bisphosphonate therapy for adult osteogenesis imperfecta.
    Siminoski, K
    Lee, KC
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S404 - S404
  • [23] Osteogenesis imperfecta.: Current therapy concept
    Lehmann, HW
    Herbold, M
    von Bodman, J
    Karbowski, A
    Stücker, R
    MONATSSCHRIFT KINDERHEILKUNDE, 2000, 148 (11) : 1024 - 1029
  • [24] Evaluating clinical efficacy and safety of palmidronate in patients with osteogenesis imperfecta.
    Lin, J
    Wang, S
    Hou, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 255 - 255
  • [25] Alendronate decreases proliferation in osteoblasts from patients with osteogenesis imperfecta.
    Leet, A. I.
    Kazarian, T.
    Jain, A.
    McBeath, R.
    Shapiro, J. R.
    Fedarko, N. S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S257 - S257
  • [26] Osteogenesis imperfecta. Clinical, functional and multidisciplinary evaluation of 65 patients
    Fano, V.
    Rodriguez Celin, M.
    del Pino, M.
    Buceta, S.
    Obregon, M. G.
    Primomo, C.
    Garcia, H.
    Miscione, H.
    Lejarraga, H.
    ANALES DE PEDIATRIA, 2010, 72 (05): : 324 - 330
  • [27] TRABECULAR BONE SCORE IN OSTEOGENESIS IMPERFECTA. IS IT USEFUL?
    Florez, H.
    Muxi, A.
    Gonzalez, F.
    Monegal, A.
    Guanabens, N.
    Peris, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1045 - 1045
  • [28] Hypertensive crisis in a case of osteogenesis imperfecta. Rare cause of sudden death
    Doberentz, E.
    Albalooshi, Y.
    Madea, B.
    RECHTSMEDIZIN, 2012, 22 (01) : 45 - 48
  • [29] Trabecular Bone Score in Osteogenesis Imperfecta. Is it useful?
    Florez, Helena
    Muxi, Africa
    Gonzalez, Eva
    Monegal, Ana
    Guanabens, Nuria
    Peris, Pilar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 121 - 121
  • [30] Quantitative ultrasonometry of the calcaneus in children with osteogenesis imperfecta.
    Kutilek, S.
    Bayer, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S454 - S454